Applonia Rose: Raising Awareness for Two Critical Cancers in February
Applonia Rose, Managing Editor at Sage Publishing, shared a post on LinkedIn:
“February: Raising Awareness for Two Critical Cancers.
This month, we recognize both Kidney Cancer Awareness Week and Esophageal Cancer Awareness Month, shedding light on two cancers that continue to affect millions globally.
According to GLOBOCAN 2022, esophageal cancer and kidney cancer rank as the 11th and 14th most common cancers worldwide. Both pose significant global health challenges, with increasing incidence rates worldwide. Addressing these cancers requires continuous research, early detection strategies, and improved treatment options.
At Technology in Cancer Research and Treatment (TCRT), we are committed to showcasing research that enhances our understanding of these cancers, from biomarkers to innovative therapies.
Here are a few impactful articles published recently:
- Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles.
- A Review of Hedgehog Signaling in Radioresistant Esophageal Cancer: Potential Treatment Target.
- Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
- Rad51 and Systemic Inflammatory Indicators as Novel Prognostic Markers in Esophageal Squamous Cell Carcinoma.
- Cone Beam Computed Tomography Image Fusion with Cross Sectional Images for Percutaneous Renal Tumor Ablation: Preliminary Data.
Let’s use this month to drive awareness, encourage screenings, and support ongoing research efforts!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023